Oxidative stress markers and insulin pump therapy

Completed

• Conditions: Type 1 diabetes; Nutritional, Metabolic, Endocrine; Insulin-dependent diabetes mellitus

• Registration Number: ISRCTN12081042
• Lead Sponsor: niversity of the Highlands and Islands (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-09-09
• Last Update Posted: 19 December 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

1. Patients with type 1 diabetes
2. Group A: patients not on insulin pump therapy and not on statin n=12
3. Group B: patients not on insulin pump therapy, but on statin n=12
4. Group C: patients on insulin pump therapy > 6 months and not on a statin n=12
5. Group D: patients on insulin pump therapy > 6 months and on a statin n=12

Exclusion Criteria

1. Type 2 diabetes
2. Very poor glucose control (HbA1c > 84 mmol/mol (10%)
3. Renal impairment (eGFR < 60ml/min/kg)
4. Recently diagnosed patients (<5 years)
5. Smokers or recently stopped (<6 months) ex-smokers
6. Chronic inflammatory disease (e.g. rheumatoid arthritis, Inflammatory bowel disease, asthma, chronic obstructive pulmonary disease)

Study & Design

• Study Type: Observational
• Study Design: Not specified